Pamela Velazquez
Physician Assistant · McAllen, TXNPI 1417124843
Payments from drug & device makers
Across 265 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$755
- Lilly USA, LLC$631
- AstraZeneca$444
- AbbVie$422
- Amarin Pharma, Inc.$364
- GSK$336
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,49496%
- Education$1894%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $755 |
| Lilly USA, LLC | 47 | $631 |
| AstraZeneca | 25 | $444 |
| AbbVie | 25 | $422 |
| Amarin Pharma, Inc. | 21 | $364 |
| GSK | 18 | $336 |
| Abbott | 12 | $253 |
| Astellas Pharma US Inc | 7 | $248 |
| Boehringer Ingelheim | 12 | $240 |
| Amgen | 13 | $207 |
| Pfizer | 8 | $141 |
| Esperion Therapeutics, Inc. | 5 | $95 |
| Ironwood Pharmaceuticals, Inc | 7 | $91 |
| Dexcom, Inc. | 2 | $81 |
| Biohaven Pharmaceuticals, Inc. | 1 | $62 |
| Organon | 2 | $46 |
| Optinose US, Inc. | 2 | $44 |
| Sanofi Pasteur Inc. | 3 | $40 |
| Johnson & Johnson | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $30 |
| Lexicon Pharmaceuticals, Inc. | 1 | $26 |
| Bayer | 1 | $25 |
| Genentech USA, Inc. | 2 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Phadia US Inc. | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$4,682 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 50 | $68,721 |
| FarxigaDapagliflozin Propanediol | 31 | $33,509 |
| JardianceEmpagliflozin | 23 | $33,320 |
| MounjaroTirzepatide | 22 | $31,204 |
| VascepaIcosapent Ethyl | 38 | $27,268 |
| LinzessLinaclotide | 19 | $24,749 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $10,955 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $8,091 |
| Icosapent Ethyl | 20 | $7,946 |
| JanuviaSitagliptin Phosphate | 13 | $7,767 |
| Rosuvastatin Calcium | 138 | $1,756 |
| Atorvastatin Calcium | 177 | $1,295 |
| Levothyroxine Sodium | 123 | $1,118 |
| Diclofenac Sodium | 16 | $1,071 |
| Losartan Potassium | 68 | $637 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $755 | $68,72150 claims |
| AstraZenecaFarxiga | $444 | $33,50931 claims |
| Boehringer IngelheimJardiance | $240 | $33,32023 claims |
| Lilly USA, LLCMounjaro | $631 | $31,20422 claims |
| AbbVieLinzess | $422 | $24,74919 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.
Other physician assistant in McAllen
- Cynthia TrickettDallas$1.3M
- Kristine KuceraMelissa$797K
- Selina SantosAustin$543K
- Matthew BrunoMcKinney$538K
- Anthony DerenciusSan Antonio$507K
- Brooke HodnickSouthlake$479K
- Holly GloverArlington$418K
- Kirk GautierAthens$416K
- Jaime RomanPlano$338K
- Michael WhiteDallas$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.